Claus Moller decreased its stake in Ebix Inc (EBIX) by 0.9% based on its latest 2016Q4 regulatory filing with the SEC. The hedge fund run by Claus Moller held 1.62M shares of the technology company at the end of 2016Q4, valued at $92.42 million, down from 1.63M at the end of the previous reported quarter. Eqis Capital Management Inc. now owns 8,609 shares of the biotechnology company's stock worth $1,045,000 after buying an additional 51 shares in the last quarter. Comcast Corp now has $189.24 billion valuation.
Shares of Ligand Pharmaceuticals (LGND) traded down 0.2913% on Tuesday, reaching $126.6002. It has outperformed by 12.26% the S&P500. Kornitzer Capital Management Inc. LS Investment Advisors LLC increased its position in shares of Ligand Pharmaceuticals by 43.2% in the first quarter. (LGND)'s stock rose 7.66%. The Summit Creek Advisors Llc holds 61,647 shares with $6.26M value, down from 149,422 last quarter. Riggs Asset Managment Company who had been investing in Ligand Pharm Inc Cl B for a number of months, seems to be less bullish one the $2.65B market cap company. 14,200 are owned by Virginia Retirement Systems Et Al. About 160,085 shares traded.
For the next year, sell-side analysts are expecting EPS growth of 39.23% for Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). It has underperformed by 19.57% the S&P500.
Investors sentiment increased to 0.97 in 2016 Q4. It fall, as 41 investors sold NOW shares while 113 reduced holdings. 158.52 million shares or 2.18% less from 162.05 million shares in 2016Q3 were reported. Teachers Retirement Of The State Of Kentucky has 7,000 shares. Glenmede Na holds 441 shares. Bnp Paribas Arbitrage invested 0% of its portfolio in Ebix Inc (NASDAQ:EBIX). (NASDAQ:LGND). 91,885 were accumulated by Eaton Vance. $4.13 million worth of Ligand Pharmaceuticals Inc. Citigroup Inc invested in 17,047 shares or 0% of the stock. Waddell Reed invested 0.03% of its portfolio in PepsiCo, Inc. Pictet Asset Ltd has invested 0.07% of its portfolio in ServiceNow Inc (NYSE:NOW). Stephens Incorporated Ar holds 991 shares. Bank & Trust Of Mellon Corporation holds 0.02% in Ligand Pharmaceuticals Inc. Following the sale, the chief executive officer now owns 144,654 shares of the company's stock, valued at approximately $18,081,750. It also reduced Community Bank System Inc. Eagle Asset Management Inc. now owns 490,841 shares of the biotechnology company's stock valued at $59,588,000 after buying an additional 35,289 shares during the period.
Since February 27, 2017, it had 0 insider purchases, and 7 insider sales for $11.11 million activity. The insider LUDDY FREDERIC B sold 102,000 shares worth $9.69M. $630,650 worth of Ligand Pharmaceuticals Inc. The insider Aryeh Jason sold $4.13 million.
About 716,415 shares traded. Therefore 38% are positive.
Analysts await Ebix Inc (NASDAQ:EBIX) to report earnings on August, 14. Roth Capital maintained Ligand Pharmaceuticals Inc. BidaskClub downgraded Ligand Pharmaceuticals from a buy rating to a hold rating in a report on Tuesday, August 1st. The stock has "Buy" rating by Citigroup on Monday, June 19. The firm has "Buy" rating by Canaccord Genuity given on Thursday, June 1. The firm has "Overweight" rating given on Wednesday, April 13 by Stephens. The rating was maintained by Mizuho on Thursday, January 26 with "Buy".
Ligand Pharmaceuticals Incorporated has a consensus outperform rating from 5 Wall Street analysts, and the number of shares now sold short amount to at least 23.66% of shares outstanding. Therefore 80% are positive. On average, equities analysts anticipate that Ligand Pharmaceuticals Incorporated will post $2.95 EPS for the current fiscal year. (NYSE:PEP) on Friday, September 30 with "Buy" rating. The firm has "Buy" rating given on Friday, December 18 by TH Capital.
10/05/2016 - Ligand Pharmaceuticals Incorporated had its "buy" rating reiterated by analysts at H.C. Wainwright. Four research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. The company was maintained on Monday, September 21 by Roth Capital. On Thursday, November 19 the stock rating was maintained by TH Capital with "Buy". The stock of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) has "Buy" rating given on Wednesday, September 30 by Roth Capital. (NASDAQ:LGND). Sei Communication reported 13,281 shares or 0.01% of all its holdings. ValuEngine upgraded Ligand Pharmaceuticals from a "sell" rating to a "hold" rating in a research report on Thursday, June 22nd. They now have a hold rating on the biotechnology company's stock.
Investors sentiment increased to 1.2 in Q4 2016. Its up 0.12, from 1.08 in 2016Q3. Whittier reported 20 shares or 0% of all its holdings. Highlander Cap Mgmt Ltd reported 9,874 shares. Point72 Asia (Hong Kong) Limited reported 0.01% stake. Dupont Cap Management accumulated 8,502 shares. The original version of this report can be accessed at https://www.chaffeybreeze.com/2017/08/11/deutsche-bank-ag-increases-ligand-pharmaceuticals-incorporated-nasdaqlgnd-price-target-to-104-00.html. It also increased its holding in Blackhawk Network Hldgs Inc (NASDAQ:HAWK) by 191,474 shares in the quarter, for a total of 3.00 million shares, and has risen its stake in Cbiz Inc (NYSE:CBZ). Profund Advsr Limited Liability Company holds 0.04% of its portfolio in Ebix Inc (NASDAQ:EBIX) for 16,279 shares.
07/22/2014 - Empire Asset Management began new coverage on Ligand Pharmaceuticals Incorporated giving the company a "sell" rating. (NASDAQ:LGND). Spot Trading Ltd Liability Corporation has 7,079 shares for 0.02% of their portfolio. (NASDAQ:LGND) for 3,055 shares. Commonwealth Equity Serv reported 4,680 shares. The Maryland-based Proshare Lc has invested 0.02% in Ligand Pharmaceuticals Inc.
- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.